​

Funding Round

Series D - Mirxes

Series D - Mirxes

Investment Firm

Overview

Mirxes is an RNA technology company that develops blood-based miRNA test kits for early disease detection.

Announced Date

Jul 25, 2023

Funding Type

Series D

Highlights

Location

Asia

Social

Investor Lead

China Fellow Partners

China Fellow Partners

China Fellow Partners is a early_stage_venture and late_stage_venture and private_equity and seed firm.

Participant Investors

5

Investor Name
Participant InvestorNHH Ventures
Participant InvestorChina Fellow Partners
Participant InvestorThe Agency for Science, Technology and Research
Participant InvestorMitsui & Co
Participant InvestorEDBI

Round Details and Background

Mirxes raised $50000000 on 2023-07-25 in Series D

Mirxes is an RNA technology company that develops blood-based miRNA test kits for early disease detection.

Company Funding History

4

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Dec 01, 2016
Seed Round - Mirxes
1-4.0M
Jul 08, 2021
Series C - Mirxes
6-77.0M
Feb 22, 2022
Series C - Mirxes
8-87.0M
Jul 25, 2023
Series D - Mirxes
5-50.0M

Recent Activity

There is no recent news or activity for this profile.